Lyft valued at $24.3 billion in first ride-hailing IPO
(Reuters) – Lyft Inc was valued at $24.3 billion in the first initial public offering (IPO) of a ride-hailing startup on Thursday, raising more than it had set off to…
by October Gallery
(Reuters) – Lyft Inc was valued at $24.3 billion in the first initial public offering (IPO) of a ride-hailing startup on Thursday, raising more than it had set off to…
FRANKFURT (Reuters) – German pharma group Merck KGaA launched a hostile $5.9 billion all-cash takeover offer for Versum Materials on Tuesday to boost its presence in the semiconductor materials market…
NEW YORK (Reuters) – Dow Inc will replace DowDuPont Inc in the Dow Jones Industrial Average following the chemical corporation’s breakup into three smaller companies, S&P Dow Jones Indices said…
NEW YORK (Reuters) – U.S. stocks gained on Tuesday, with financials snapping a five-day losing streak as Treasury yields stabilized above 15-month lows. The S&P 500 financial index gained 1.1…
FILE PHOTO: A Pinterest banner hangs on the facade of the New York Stock Exchange (NYSE) in New York City, U.S., September 22, 2017. REUTERS/Brendan McDermid (Reuters) – Pinterest Inc,…
FILE PHOTO: An aerial photo shows Boeing 737 MAX airplanes parked at the Boeing Factory in Renton, Washington, U.S. March 21, 2019. REUTERS/Lindsey Wasson/File Photo WASHINGTON (Reuters) – The chairman…
NEW YORK (Reuters) – Wall Street stocks sold off sharply on Friday, with all three major U.S. stock indexes posting their biggest one-day percentage declines since Jan. 3, as weak…
JAKARTA/CHICAGO (Reuters) – Indonesian airline Garuda plans to cancel a $6 billion order for Boeing 737 MAX jets because some passengers say they would be frightened to board the plane…
NEW YORK (Reuters) – Wall Street led global stocks higher on Thursday on the back of upbeat economic data, while the dollar rallied despite the Federal Reserve’s uber-dovish stance as…
CHICAGO/TOKYO (Reuters) – Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find…